Paid sick leave could be a sticking point as Senate considers coronavirus relief bill


The Senate is expected this week to pass a coronavirus relief bill that has President Trump's approval, but it could potentially be held up a bit.
The House of Representatives early on Saturday passed an economic relief bill negotiated between House Speaker Nancy Pelosi (D-Calif.) and Treasury Secretary Steven Mnuchin in response to the ongoing coronavirus pandemic. Trump said he "fully" supports the bill, which provides free coronavirus testing and requires companies with fewer than 500 employees provide paid sick leave.
The Senate is expected to pass the coronavirus bill after Senate Majority Leader Mitch McConnell (R-Ky.) canceled a planned recess. But Bloomberg reports that action could be delayed "up to several days" as the bill is "running into resistance from some Republicans worried about the impact of a temporary paid sick leave provision on small businesses."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sen. Ron Johnson (R-Wisc.) is one of those senators objecting paid sick leave provision, saying he hopes the Senate passes a "bill that does more good than harm — or, if it won't, pass nothing at all." Bloomberg notes that "Senate rules allow any one senator to delay a final vote for days." Mnuchin said over the weekend said "we'll work with the Senate on whatever minor changes we need."
In addition, Bloomberg reports the House has to "pass technical corrections to the bill, which was drafted on the fly," which "adds another wrinkle that could slow final action in the Senate."
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.
-
July 13 editorial cartoons
Cartoons Sunday's political cartoons include new TSA rules, FEMA cuts, and Volodymyr Zelenskyy complimenting Donald Trump's new wardrobe
-
5 weather-beaten cartoons about the Texas floods
Cartoons Artists take on funding cuts, politicizing tragedy, and more
-
What has the Dalai Lama achieved?
The Explainer Tibet’s exiled spiritual leader has just turned 90, and he has been clarifying his reincarnation plans
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
RFK Jr. visits Texas as 2nd child dies from measles
Speed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths